ARTICLE | Management Tracks
Juan Andres to retire from Moderna
Plus: Avidity promotes Flanagan, a new chair at Ansa
February 24, 2023 2:07 AM UTC
In its 4Q22 financial results, Moderna Inc. (NASDAQ:MRNA) announced that President of Strategic Partnerships and Enterprise Expansion Juan Andres will retire in May. Andres joined the company in 2017 as SVP of manufacturing, quality and technical development before becoming chief technical operations and quality officer in 2018. In this role, he led his team to manufacture more than 800 million doses of COVID-19 vaccine in 2021.
Antibody oligonucleotide conjugate therapy company Avidity Biosciences Inc. (NASDAQ:RNA) promoted CTO Michael Flanagan to chief scientific and technical officer. Flanagan replaces Arthur Levin, who was named distinguished scientist and strategic leader and has joined the board...